Calton & Associates, Inc. Edwards Lifesciences Corp Transaction History

Calton & Associates, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 09, 2019	SELL	$55.74 - $64.41 $151,111 - $174,615	-2,711 Closed	0 $0
Q1 2019 Apr 25, 2019	BUY	$47.89 - $64.05 $129,829 - $173,639	2,711 New	2,711 $519,000
Q4 2018 Feb 11, 2019	SELL	$46.41 - $56.94 $85,951 - $105,452	-1,852 Closed	0 $0
Q3 2018 Oct 24, 2018	BUY	$45.7 - $58.03 $4,981 - $6,325	109 Added 6.25%	1,852 $323,000
Q2 2018 Aug 10, 2018	BUY	$42.45 - $51.3 $10,952 - $13,235	258 Added 17.37%	1,743 $244,000
Q1 2018 Apr 17, 2018	BUY	$37.19 - $47.45 $55,227 - $70,463	1,485 New	1,485 $207,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.